• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The genetics of hypertrophic cardiomyopathy: Teare redux.

作者信息

Watkins H, Ashrafian H, McKenna W J

机构信息

Department of Cardiovascular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.

出版信息

Heart. 2008 Oct;94(10):1264-8. doi: 10.1136/hrt.2008.154104. Epub 2008 Jul 24.

DOI:10.1136/hrt.2008.154104
PMID:18653576
Abstract
摘要

相似文献

1
The genetics of hypertrophic cardiomyopathy: Teare redux.肥厚型心肌病的遗传学：重温蒂尔研究
Heart. 2008 Oct;94(10):1264-8. doi: 10.1136/hrt.2008.154104. Epub 2008 Jul 24.
2
A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis.PRKAG2基因中的一种新突变导致肥厚型心肌病伴传导系统疾病和肌肉糖原贮积症。
Neuromuscul Disord. 2006 Mar;16(3):178-82. doi: 10.1016/j.nmd.2005.12.004. Epub 2006 Feb 17.
3
Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase.伴有磷酸化酶激酶缺乏及AMP活化蛋白激酶γ2亚基突变的致死性婴儿心脏糖原贮积病
Pediatr Res. 2007 Oct;62(4):499-504. doi: 10.1203/PDR.0b013e3181462b86.
4
Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.组成型激活的AMP激酶突变导致类似肥厚型心肌病的糖原贮积病。
J Clin Invest. 2002 Feb;109(3):357-62. doi: 10.1172/JCI14571.
5
A contemporary approach to hypertrophic cardiomyopathy.肥厚型心肌病的现代治疗方法。
Circulation. 2006 Jun 20;113(24):e858-62. doi: 10.1161/CIRCULATIONAHA.105.591982.
6
Glycogen storage diseases and cardiomyopathy.糖原贮积病与心肌病
N Engl J Med. 2005 Jun 16;352(24):2553; author reply 2553. doi: 10.1056/NEJM200506163522417.
7
AMP-activated protein kinase and familial Wolff-Parkinson-White syndrome: new perspectives on heart development and arrhythmogenesis.
Eur Heart J. 2002 May;23(9):679-81. doi: 10.1053/euhj.2001.2954.
8
Comparison of fluorescent SSCP and denaturing HPLC analysis with direct sequencing for mutation screening in hypertrophic cardiomyopathy.荧光单链构象多态性分析和变性高效液相色谱分析与直接测序法在肥厚型心肌病突变筛查中的比较
J Med Genet. 2003 May;40(5):e59. doi: 10.1136/jmg.40.5.e59.
9
Modulating phenotypic expression of the PRKAG2 cardiac syndrome.
Circulation. 2008 Jan 15;117(2):134-5. doi: 10.1161/CIRCULATIONAHA.107.747345.
10
A molecular basis for Wolff-Parkinson-White syndrome.预激综合征的分子基础。
N Engl J Med. 2001 Jun 14;344(24):1861-4. doi: 10.1056/NEJM200106143442411.

引用本文的文献

1
Copper chelation in patients with hypertrophic cardiomyopathy.铜螯合治疗肥厚型心肌病。
Open Heart. 2022 Feb;9(1). doi: 10.1136/openhrt-2021-001803.
2
CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis.CMR 技术的 T1 映射相对于基于纵向应变的相对心尖保留评估，对心脏淀粉样变性具有更高的诊断价值。
Sci Rep. 2021 Jul 30;11(1):15521. doi: 10.1038/s41598-021-94650-2.
3
Prioritizing genes for systematic variant effect mapping.优先考虑系统变异效应映射的基因。
Bioinformatics. 2021 Apr 1;36(22-23):5448-5455. doi: 10.1093/bioinformatics/btaa1008.
4
Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.通过T1映射评估的细胞和细胞外病理学对肥厚型心肌病区域收缩功能的影响。
J Cardiovasc Magn Reson. 2017 Feb 20;19(1):16. doi: 10.1186/s12968-017-0334-x.
5
Relationship between Regional Fat Distribution and Hypertrophic Cardiomyopathy Phenotype.局部脂肪分布与肥厚型心肌病表型之间的关系
PLoS One. 2016 Jul 7;11(7):e0158892. doi: 10.1371/journal.pone.0158892. eCollection 2016.
6
Contractility parameters of human β-cardiac myosin with the hypertrophic cardiomyopathy mutation R403Q show loss of motor function.携带肥厚型心肌病突变R403Q的人β-心肌肌球蛋白的收缩参数显示运动功能丧失。
Sci Adv. 2015 Oct 9;1(9):e1500511. doi: 10.1126/sciadv.1500511. eCollection 2015 Oct.
7
Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.南非限制性心肌病和局灶性心室肥厚患者的诊断差异以及两个TNNI3基因突变的鉴定，其中一个为新发现的突变，另一个为新发突变。
Cardiovasc J Afr. 2015 Mar-Apr;26(2):63-9. doi: 10.5830/CVJA-2015-019.
8
Hypertrophic Cardiomyopathy Associated with Mid-cavity Obstruction and High Left Intraventricular Pressure.肥厚型心肌病伴中腔梗阻和高左心室内压
Acta Inform Med. 2011 Dec;19(4):241-3. doi: 10.5455/aim.2011.19.241-243.
9
Hypertrophic cardiomyopathy: from mutation to functional analysis of defective protein.肥厚型心肌病：从突变到缺陷蛋白的功能分析
Croat Med J. 2011 Jun;52(3):384-91. doi: 10.3325/cmj.2011.52.384.
10
Genetic predisposition for sudden cardiac death in myocardial ischaemia: the Arrhythmia Genetics in the NEtherlandS study.心肌缺血性心脏性猝死的遗传易感性：荷兰心律失常遗传学研究
Neth Heart J. 2011 Feb;19(2):96-100. doi: 10.1007/s12471-010-0070-4. Epub 2011 Jan 28.